Cigna Medical Coverage Policy - Therapy Services: Electrodiagnostic Testing (EMG/NCV)
Customize your policy alerts
Sign up for all american_specialty_health policy alerts
Know when american_specialty_health releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage policy for nerve conduction studies, needle electromyography, neuromuscular junction testing, and somatosensory evoked potentials — describes when these electrodiagnostic tests are medically necessary, not medically necessary, or experimental/investigational for benefit plans administered by Cigna/ASH.
No material clinical or coverage changes in this revision.
Coverage Criteria for Electrodiagnostic Testing
Nerve conduction velocity testing AND needle electromyography performed together
Considered medically necessary when performed and interpreted together for any of the following indications:
Nerve conduction velocity testing performed alone
NCV testing alone is medically necessary for any of the above indications in the following clinical presentations:
Needle EMG specific indications
Somatosensory evoked potentials (SSEPs)
SSEPs are medically necessary when prior diagnostic testing has failed to confirm a diagnosis for any of the following:
Neuromuscular junction testing
Considered medically necessary for any of the following indications:
Not medically necessary (selected)
The policy lists specific not medically necessary situations:
General medical necessity criteria
Electrodiagnostic testing (EMG/NCS/SEPs) is covered when clinically indicated and performed according to professional standards. Covered when ALL of the following are met:
Clinical assessment must clearly justify planned electrodiagnostic tests
If findings would not influence care, testing is not supported
EMG and NCS should be performed together when appropriate
Exceptions must be documented in the chart
Exceptions and limits
Tests not routinely performed together or not recommended in specific situations include:
These are exceptions to the general rule that NCS and EMG be performed together
As per AANEM guidance
AANEM-based recommended test types and counts by diagnostic category
Covered when studies are individualized and guided by history and exam; AANEM recommended reasonable maximum numbers per diagnostic category referenced (Table of recommended study counts).
Frequency limits and justification for repeat testing
Repeat EDX testing is sometimes necessary; acceptable per-physician per-diagnosis limits per 12 months are specified.
Covered vs nonstandard testing
Coverage and clinical stance for automated NCV, standard NCS/EMG, and SEMG:
Supported by AANEM guidance; onsite/real‑time integration required.
Use of these devices is considered not supported by policy when used as a substitute for standard testing.
SEMG has limited clinical utility for diagnostic decision‑making.
Combined NCV and EMG medical necessity
Considered medically necessary when ALL of the following are met:
Supported by CPT code groupings and requirement that studies be performed and interpreted together on the same date of service.
NCV diagnosis codes (informational)
This excerpt contains only the diagnostic code list and does not state coverage criteria logic.
See other policy sections for medical necessity criteria and procedural limits.
NCV Diagnosis Code Mappings
Diagnosis code mapping for NCV testing entries (Table 1).
Use appropriate side and encounter/sequela coding as listed in the table.
NCV Diagnosis Code Mapping
Diagnosis codes to be used for NCV testing related to cranial nerve injury
Table lists multiple entries for side/encounter variants for clarity.
SSEPs (somatosensory evoked potentials) are restricted in this policy. SSEPs are not medically necessary for any indication other than those specifically listed in the policy and should not be used broadly (for example, for routine evaluation of lumbosacral, thoracic, or cervical root disorders) unless a listed SSEP indication applies and prior diagnostic testing has failed to confirm a diagnosis. This limitation reflects the policy position that SSEPs have a defined, narrow role (central pathway and specific CNS indications) and should not be substituted for other diagnostic evaluations.
Surface electromyography (SEMG), including paraspinal SEMG and macro EMG, is considered investigational for routine diagnostic decision-making. The policy states that the clinical utility of SEMG/HD‑sEMG and paraspinal SEMG has not been established in peer‑reviewed literature and that SEMG techniques have technical limitations (wide-area recordings, limited frequency band, low signal resolution, and susceptibility to movement artifact). As a result, SEMG, paraspinal SEMG, and macro EMG are not supported as established diagnostic modalities outside investigational or specific limited contexts such as research or movement/gait studies.
Needle electromyography (NEMG) has recognized diagnostic value but the policy identifies specific limitations. NEMG is not recommended for testing intrinsic foot muscles to evaluate proximal lesions, and definitive conclusions from paraspinal EMG are discouraged in regions with prior surgical scarring. The policy also emphasizes that NEMG performed too soon after trauma (before abnormalities would reasonably develop) is not appropriate. These restrictions align with AANEM guidance requiring that NEMG be targeted by history and exam and interpreted in the appropriate clinical timeframe.
Automated, noninvasive nerve conduction testing devices (for example, handheld or portable systems marketed for screening or rapid NCV assessment) and routine screening/monitoring programs that rely on such devices are not supported. The policy references AANEM guidance and evidence assessments indicating insufficient and inconsistent evidence that automated devices are equivalent to conventional electrodiagnostic testing; therefore automated noninvasive NCV devices and screening/monitoring with these devices are considered not medically necessary or investigational for diagnostic use or routine monitoring (for example, diabetic or ESRD polyneuropathy).
Using surface EMG (SEMG) to evaluate functional back pain or to localize spinal dysfunction for treatment is not supported by clinical trial evidence. The policy notes there are no clinical trials showing SEMG improves diagnostic accuracy or patient outcomes for back pain, and therefore SEMG for functional back pain lacks evidence as an effective diagnostic or outcome measure and is not supported for routine clinical decision‑making in this indication.
CPT and ICD-10 Coding Tables
| 95860-95864 | Limbs studied by needle electromyography |
| 95867-95870 | Needle electromyography add-on codes / concentric/monopolar variants (as listed) |
| 95885-95887 | Needle EMG additional coding (as listed) |
| 95907-95913 | Nerve conduction studies (total nerves studied) |
| No codes listed |
| 95885 | Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited |
| 95886 | Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied |
| 95887 | Needle electromyography, non-extremity (cranial nerve supplied or axial) muscle(s) done with nerve conduction, amplitude and latency/velocity study |
| 95907 | Nerve conduction studies; 1-2 studies |
| 95908 | Nerve conduction studies; 3-4 studies |
| 95909 | Nerve conduction studies; 5-6 studies |
| 95910 | Nerve conduction studies; 7-8 studies |
| 95911 | Nerve conduction studies; 9-10 studies |
| 95912 | Nerve conduction studies; 11-12 studies |
| 95913 | Nerve conduction studies; 13 or more studies |
| A30.0 | Indeterminate leprosy |
| A30.1 | Tuberculoid leprosy |
| A30.2 | Borderline tuberculoid leprosy |
| A30.3 | Borderline leprosy |
| A30.4 | Borderline lepromatous leprosy |
| A30.5 | Lepromatous leprosy |
| A30.8 | Other forms of leprosy |
| A30.9 | Leprosy, unspecified |
| A52.15 | Late syphilitic neuropathy |
| A69.20 | Lyme disease, unspecified |
| G56.02 | Carpal tunnel syndrome, left upper limb |
| G56.03 | Carpal tunnel syndrome, bilateral upper limbs |
| G56.10 | Other lesions of median nerve, unspecified upper limb |
| G56.11 | Other lesions of median nerve, right upper limb |
| G56.12 | Other lesions of median nerve, left upper limb |
| G56.13 | Other lesions of median nerve, bilateral upper limbs |
| G56.21 | Lesion of ulnar nerve, right upper limb |
| G56.22 | Lesion of ulnar nerve, left upper limb |
| G56.31 | Lesion of radial nerve, right upper limb |
| G56.32 | Lesion of radial nerve, left upper limb |
| G56.33 | Lesion of radial nerve, bilateral upper limbs |
| G56.41 | Causalgia of right upper limb |
| G56.42 | Causalgia of left upper limb |
| G56.43 | Causalgia of bilateral upper limbs |
| G56.81 | Other specified mononeuropathies of right upper limb |
| G56.82 | Other specified mononeuropathies of left upper limb |
| G56.83 | Other specified mononeuropathies of bilateral upper limbs |
| G56.91 | Unspecified mononeuropathy of right upper limb |
| G56.92 | Unspecified mononeuropathy of left upper limb |
| G56.93 | Unspecified mononeuropathy of bilateral upper limbs |
| G57.00 | Lesion of sciatic nerve, unspecified lower limb |
| G57.01 | Lesion of sciatic nerve, right lower limb |
| G57.02 | Lesion of sciatic nerve, left lower limb |
| G57.03 | Lesion of sciatic nerve, bilateral lower limbs |
| G57.10 | Meralgia paresthetica, unspecified lower limb |
| G57.11 | Meralgia paresthetica, right lower limb |
| G57.12 | Meralgia paresthetica, left lower limb |
| G57.13 | Meralgia paresthetica, bilateral lower limbs |
| G57.20 | Lesion of femoral nerve, unspecified lower limb |
| G57.21 | Lesion of femoral nerve, right lower limb |
| G57.22 | Lesion of femoral nerve, left lower limb |
| G57.23 | Lesion of femoral nerve, bilateral lower limbs |
| G57.30 | Lesion of lateral popliteal nerve, unspecified lower limb |
| G57.31 | Lesion of lateral popliteal nerve, right lower limb |
| G57.32 | Lesion of lateral popliteal nerve, left lower limb |
| G57.33 | Lesion of lateral popliteal nerve, bilateral lower limbs |
| G57.40 | Lesion of medial popliteal nerve, unspecified lower limb |
| G57.41 | Lesion of medial popliteal nerve, right lower limb |
| G57.42 | Lesion of medial popliteal nerve, left lower limb |
| G57.43 | Lesion of medial popliteal nerve, bilateral lower limbs |
| G57.50 | Tarsal tunnel syndrome, unspecified lower limb |
| G57.51 | Tarsal tunnel syndrome, right lower limb |
| G57.52 | Tarsal tunnel syndrome, left lower limb |
| G57.53 | Tarsal tunnel syndrome, bilateral lower limbs |
| G57.60 | Lesion of plantar nerve, unspecified lower limb |
| G57.61 | Lesion of plantar nerve, right lower limb |
| G57.62 | Lesion of plantar nerve, left lower limb |
| G57.63 | Lesion of plantar nerve, bilateral lower limbs |
| G57.70 | Causalgia of unspecified lower limb |
| G57.71 | Causalgia of right lower limb |
| G57.72 | Causalgia of left lower limb |
| G57.73 | Causalgia of bilateral lower limbs |
| G57.80 | Other specified mononeuropathies of unspecified lower limb |
| G57.81 | Other specified mononeuropathies of right lower limb |
| G57.82 | Other specified mononeuropathies of left lower limb |
| G57.83 | Other specified mononeuropathies of bilateral lower limbs |
| G57.90 | Unspecified mononeuropathy of unspecified lower limb |
| G57.91 | Unspecified mononeuropathy of right lower limb |
| G57.92 | Unspecified mononeuropathy of left lower limb |
| G57.93 | Unspecified mononeuropathy of bilateral lower limbs |
| G58.7 | Mononeuritis multiplex |
| G58.8 | Other specified mononeuropathies |
| G58.9 | Other specified mononeuropathies, unspecified |
| G60.1 | Hereditary motor and sensory neuropathy = Refsum's disease |
| G60.2 | Hereditary motor and sensory neuropathy = Neuropathy in association with hereditary ataxia |
| G60.3 | Hereditary motor and sensory neuropathy = Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G60.9 | Hereditary and idiopathic neuropathy, unspecified |
| G61.0 | Guillain-Barre syndrome |
| G61.81 | Chronic inflammatory demyelinating polyneuritis |
| G61.82 | Multifocal motor neuropathy |
| G61.89 | Other inflammatory polyneuropathies |
| G61.9 | Inflammatory polyneuropathy, unspecified |
| G62.0 | Drug-induced polyneuropathy |
| G62.1 | Alcoholic polyneuropathy |
| G62.2 | Polyneuropathy due to other toxic agents |
| G62.81 | Critical illness polyneuropathy |
| G62.82 | Radiation-induced polyneuropathy |
| G62.89 | Other specified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G63 | Polyneuropathy in diseases classified elsewhere |
| G65.0 | Sequelae of Guillain-Barre syndrome |
| G65.1 | Sequelae of other inflammatory polyneuropathy |
| G65.2 | Sequelae of toxic polyneuropathy |
| G70.00 | Myasthenia gravis without (acute) exacerbation |
| G70.01 | Myasthenia gravis with (acute) exacerbation |
| G70.1 | Toxic myoneural disorders |
| G70.2 | Congenital and developmental myasthenia |
| G70.80 | Lambert-Eaton syndrome, unspecified |
| G70.81 | Lambert-Eaton syndrome in disease classified elsewhere |
| G70.89 | Other specified myoneural disorders |
| G70.9 | Myoneural disorder, unspecified |
| G71.00 | Muscular dystrophy, unspecified |
| G71.01 | Duchenne or Becker muscular dystrophy |
| G71.02 | Facioscapulohumeral muscular dystrophy |
| G71.031 | Autosomal dominant limb girdle muscular dystrophy |
| G71.032 | Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction |
| G71.033 | Limb girdle muscular dystrophy due to dysferlin dysfunction |
| G71.0340 | Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified |
| G71.0341 | Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction |
| G71.0342 | Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction |
| G71.0349 | Limb girdle muscular dystrophy due to other sarcoglycan dysfunction |
| G71.035 | Limb girdle muscular dystrophy due to anoctamin-5 dysfunction |
| G71.036 | Limb girdle muscular dystrophy due to fukutin related protein dysfunction |
| G71.038 | Other limb girdle muscular dystrophy |
| G71.039 | Limb girdle muscular dystrophy, unspecified |
| G71.09 | Other specified muscular dystrophies |
| G71.11 | Myotonic muscular dystrophy |
| G71.12 | Myotonia congenita / Myotonic chondrodystrophy |
| G71.13 | Myotonic chondrodystrophy |
| G71.14 | Drug induced myotonia |
| G71.19 | Other specified myotonic disorders |
| G71.20 | Congenital myopathy, unspecified |
| G71.21 | Nemaline myopathy |
| G71.220 | X-linked myotubular myopathy |
| G71.228 | Other centronuclear myopathy |
| G71.29 | Other centronuclear myopathy / other congenital myopathy |
| G72.0 | Drug-induced myopathy |
| G72.1 | Alcoholic myopathy |
| G72.2 | Myopathy due to other toxic agents |
| G72.3 | Periodic paralysis |
| G72.81 | Critical illness myopathy |
| G72.89 | Other specified myopathies |
| G72.9 | Myopathy, unspecified |
| G73.1 | Lambert-Eaton syndrome in neoplastic disease |
| G73.7 | Myopathy in diseases classified elsewhere |
| G80.0 | Spastic quadriplegic cerebral palsy |
| G80.1 | Spastic diplegic cerebral palsy |
| G80.2 | Spastic hemiplegic cerebral palsy |
| G80.3 | Athetoid cerebral palsy |
| G80.4 | Ataxic cerebral palsy |
| G80.8 | Other cerebral palsy |
| G80.9 | Cerebral palsy, unspecified |
| G81.01 | Flaccid hemiplegia affecting right dominant side |
| G81.02 | Flaccid hemiplegia affecting left dominant side |
| G81.03 | Flaccid hemiplegia affecting right nondominant side |
| G81.04 | Flaccid hemiplegia affecting left nondominant side |
| G81.11 | Spastic hemiplegia affecting right dominant side |
| G81.12 | Spastic hemiplegia affecting left dominant side |
| G81.13 | Spastic hemiplegia affecting right nondominant side |
| G81.14 | Spastic hemiplegia affecting left nondominant side |
| G81.91 | Hemiplegia, unspecified affecting right dominant side |
| G81.92 | Hemiplegia, unspecified affecting left dominant side |
| G82.20 | Paraplegia, unspecified |
| G82.21 | Paraplegia, complete |
| G82.22 | Paraplegia, incomplete |
| G82.50 | Quadriplegia, unspecified |
| G82.51 | Quadriplegia, C1-C4 complete |
| G82.52 | Quadriplegia, C1-C4 incomplete |
| G82.53 | Quadriplegia, C5-C7 complete |
| G82.54 | Quadriplegia, C5-C7 incomplete |
| H02.401 | Unspecified ptosis of right eyelid |
| H02.402 | Unspecified ptosis of left eyelid |
| H02.403 | Unspecified ptosis of bilateral eyelids |
| H02.411 | Mechanical ptosis of right eyelid |
| H02.412 | Mechanical ptosis of left eyelid |
| H02.413 | Mechanical ptosis of bilateral eyelids |
| H02.419 | Mechanical ptosis of unspecified eyelid |
| H02.421 | Myogenic ptosis of right eyelid |
| H02.431 | Paralytic ptosis of right eyelid |
| H02.432 | Paralytic ptosis of left eyelid |
| H02.439 | Paralytic ptosis unspecified eyelid |
| H46.2 | Nutritional optic neuropathy |
| H46.3 | Toxic optic neuropathy |
| H47.011 | Ischemic optic neuropathy, right eye |
| H47.012 | Ischemic optic neuropathy, left eye |
| H47.013 | Ischemic optic neuropathy, bilateral |
| H49.01 | Third (oculomotor) nerve palsy, right eye |
| H49.02 | Third (oculomotor) nerve palsy, left eye |
| H49.40 | Progressive external ophthalmoplegia, unspecified eye |
| H49.41 | Progressive external ophthalmoplegia, right eye |
| H49.42 | Progressive external ophthalmoplegia, left eye |
| H49.43 | Progressive external ophthalmoplegia, bilateral |
| H49.881 | Other paralytic strabismus, right eye |
| H49.882 | Other paralytic strabismus, left eye |
| H49.883 | Other paralytic strabismus, left eye (duplicate listing in source) |
| H49.889 | Other paralytic strabismus, bilateral |
| H49.9 | Other paralytic strabismus, unspecified eye |
| H50.00 | Unspecified esotropia |
| H50.05 | Alternating esotropia |
| H50.06 | Alternating esotropia with A pattern |
| H50.07 | Alternating esotropia with V pattern |
| H50.08 | Alternating esotropia with other noncomitancies |
| H50.10 | Unspecified exotropia |
| H50.111 | Monocular exotropia, right eye |
| H50.112 | Monocular exotropia, left eye |
| H50.121 | Monocular exotropia with A pattern, right eye |
| H50.122 | Monocular exotropia with A pattern, left eye |
| H50.131 | Monocular exotropia with V pattern, right eye |
| H50.15 | Alternating exotropia |
| H50.16 | Alternating exotropia with A pattern |
| H50.17 | Alternating exotropia with V pattern |
| H50.18 | Alternating exotropia with other noncomitancies |
| H50.22 | Vertical strabismus, right eye |
| H50.30 | Unspecified intermittent heterotropia |
| H50.311 | Intermittent monocular esotropia, right eye |
| H50.312 | Intermittent monocular esotropia, left eye |
| H50.32 | Intermittent alternating esotropia |
| H50.331 | Intermittent monocular exotropia, right eye |
| H50.34 | Intermittent alternating exotropia |
| H50.40 | Unspecified heterotropia |
| H50.411 | Cyclotropia, right eye |
| H50.412 | Cyclotropia, left eye |
| H50.42 | Monofixation syndrome |
| H50.43 | Accommodative component in esotropia |
| H50.50 | Unspecified heterophoria |
| H50.51 | Esophoria |
| H50.52 | Exophoria |
| H50.53 | Vertical heterophoria |
| H50.55 | Alternating heterophoria |
| H50.60 | Mechanical strabismus, unspecified |
| H50.611 | Brown's sheath syndrome, right eye |
| H50.612 | Brown's sheath syndrome, left eye |
| H50.69 | Other mechanical strabismus |
| H50.811 | Duane's syndrome, right eye |
| H50.812 | Duane's syndrome, left eye |
| H50.89 | Other specified strabismus |
| H51.0 | Palsy (spasm) of conjugate gaze |
| H51.11 | Convergence insufficiency |
| H51.12 | Convergence excess |
| H51.21 | Internuclear ophthalmoplegia, right eye |
| H51.22 | Internuclear ophthalmoplegia, left eye |
| H51.23 | Internuclear ophthalmoplegia, bilateral |
| H51.8 | Other specified disorders of binocular movement |
| H51.9 | Unspecified disorder of binocular movement |
| H53.2 | Diplopia |
| H71.01 | Cholesteatoma of attic, right ear |
| H71.02 | Cholesteatoma of attic, left ear |
| H71.03 | Cholesteatoma of attic, bilateral |
| H72.01 | Central perforation of tympanic membrane, right ear |
| H72.02 | Central perforation of tympanic membrane, left ear |
| H72.03 | Central perforation of tympanic membrane, bilateral |
| I63.30 | Cerebral infarction due to thrombosis of unspecified cerebral artery |
| I63.311 | Cerebral infarction due to thrombosis of right middle cerebral artery |
| I63.312 | Cerebral infarction due to thrombosis of left middle cerebral artery |
| I63.313 | Cerebral infarction due to thrombosis of bilateral middle cerebral arteries |
| I63.319 | Cerebral infarction due to thrombosis of unspecified middle cerebral artery |
| I63.321 | Cerebral infarction due to thrombosis of right anterior cerebral artery |
| I63.322 | Cerebral infarction due to thrombosis of left anterior cerebral artery |
| I63.323 | Cerebral infarction due to thrombosis of bilateral anterior arteries |
| I63.329 | Cerebral infarction due to thrombosis of unspecified anterior cerebral artery |
| I63.331 | Cerebral infarction due to thrombosis of right posterior cerebral artery |
| I63.332 | Cerebral infarction due to thrombosis of left posterior cerebral artery |
| I63.333 | Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries |
| I63.339 | Cerebral infarction due to thrombosis of unspecified posterior cerebral artery |
| I63.341 | Cerebral infarction due to thrombosis of right cerebellar artery |
| I63.342 | Cerebral infarction due to thrombosis of left cerebellar artery |
| I63.343 | Cerebral infarction due to thrombosis of bilateral cerebellar arteries |
| I63.349 | Cerebral infarction due to thrombosis of unspecified cerebellar artery |
| I63.39 | Cerebral infarction due to thrombosis of other cerebral artery |
| I63.40 | Cerebral infarction due to embolism of unspecified cerebral artery |
| I63.411 | Cerebral infarction due to embolism of right middle cerebral artery |
| I63.412 | Cerebral infarction due to embolism of left middle cerebral artery |
| I63.413 | Cerebral infarction due to embolism of bilateral middle cerebral arteries |
| I63.419 | Cerebral infarction due to embolism of unspecified middle cerebral artery |
| I63.421 | Cerebral infarction due to embolism of right anterior cerebral artery |
| I63.422 | Cerebral infarction due to embolism of left anterior cerebral artery |
| I63.423 | Cerebral infarction due to embolism of bilateral anterior cerebral arteries |
| I63.429 | Cerebral infarction due to embolism of unspecified anterior cerebral artery |
| I63.431 | Cerebral infarction due to embolism of right posterior cerebral artery |
| I63.432 | Cerebral infarction due to embolism of left posterior cerebral artery |
| I63.433 | Cerebral infarction due to embolism of bilateral posterior cerebral arteries |
| I63.439 | Cerebral infarction due to embolism of unspecified posterior cerebral artery |
| I63.49 | Cerebral infarction due to embolism of other cerebral artery |
| I63.50 | Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery |
| I63.511 | Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery |
| I63.512 | Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery |
| I63.513 | Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries |
| I63.519 | Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery |
| I63.521 | Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery |
| I63.522 | Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery |
| I63.523 | Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery |
| I63.529 | Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries |
| I69.031 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side |
| I69.032 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side |
| I66.3 | Occlusion and stenosis of unspecified posterior cerebral artery |
| I66.8 | Occlusion and stenosis of other cerebral arteries |
| I66.9 | Occlusion and stenosis of unspecified cerebral artery |
| I69.031 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right |
| I69.032 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left |
| I69.033 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side |
| I69.034 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side |
| I69.039 | Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side |
| I69.041 | Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right |
| I69.042 | Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left |
| M05.552 | Rheumatoid polyneuropathy with rheumatoid arthritis of right hip |
| M05.559 | Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip |
| M05.561 | Rheumatoid polyneuropathy with rheumatoid arthritis of right knee |
| M05.562 | Rheumatoid polyneuropathy with rheumatoid arthritis of left knee |
| M05.569 | Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee |
| M05.571 | Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot |
| M05.572 | Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot |
| M05.579 | Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot |
| M05.59 | Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites |
| M05.A | Abnormal rheumatoid factor and anti-citrullinated protein antibody with rheumatoid arthritis |
| M50.023 | Cervical disc disorder at C6-C7 level with myelopathy |
| M50.03 | Cervical disc disorder with myelopathy, cervicothoracic region |
| M50.10 | Cervical disc disorder with radiculopathy, unspecified cervical region |
| M50.11 | Cervical disc disorder with radiculopathy, high cervical region |
| M50.120 | Mid-cervical disc disorder, unspecified level |
| M50.121 | Cervical disc disorder at C4-C5 level with radiculopathy |
| M50.122 | Cervical disc disorder at C5-C6 level with radiculopathy |
| M50.123 | Cervical disc disorder at C6-C7 level with radiculopathy |
| M50.13 | Cervical disc disorder with radiculopathy, cervicothoracic region |
| M50.20 | Other cervical disc displacement, unspecified cervical region |
| O26.821 | Pregnancy related peripheral neuritis, first trimester |
| O26.822 | Pregnancy related peripheral neuritis, second trimester |
| O26.823 | Pregnancy related peripheral neuritis, third trimester |
| O26.829 | Pregnancy related peripheral neuritis, unspecified trimester |
| P11.3 | Birth injury to facial nerve |
| P11.4 | Birth injury to other cranial nerves |
| P11.5 | Birth injury to spine and spinal cord |
| P14.0 | Erb's paralysis due to birth injury |
| P14.1 | Klumpke's paralysis due to birth injury |
| P14.3 | Other brachial plexus birth injuries |
| R13.13 | Dysphagia, pharyngeal phase |
| R13.14 | Dysphagia, pharyngoesophageal phase |
| R13.19 | Other dysphagia |
| R15.0 | Incomplete defecation |
| R15.1 | Fecal smearing |
| R15.2 | Fecal urgency |
| R15.9 | Full incontinence of feces |
| R20.0 | Anesthesia of skin |
| R20.1 | Hypoesthesia of skin |
| R20.2 | Paresthesia of skin |
| R27.0 | Ataxia, unspecified |
| R27.8 | Other lack of coordination |
| R27.9 | Unspecified lack of coordination |
| R29.0 | Tetany |
| R29.1 | Meningismus |
| R29.2 | Abnormal reflex |
| R29.5 | Transient paralysis |
| R29.818 | Other symptoms and signs involving the nervous system |
| R29.891 | Ocular torticollis |
| R29.90 | Unspecified symptoms and signs involving the nervous system |
| S04.10XD | Injury of oculomotor nerve, unspecified side, subsequent encounter |
| S04.10XS | Injury of oculomotor nerve, unspecified side, sequela |
| S04.11XA | Injury of oculomotor nerve, right side |
| S04.11XS | Injury of oculomotor nerve, right side, sequela |
| S04.12XA | Injury of oculomotor nerve, left side |
| S04.12XS | Injury of oculomotor nerve, left side, sequela |
| S04.20XD | Injury of trochlear nerve, unspecified side, subsequent encounter |
| S04.20XS | Injury of trochlear nerve, unspecified side, sequela |
| S04.21XA | Injury of trochlear nerve, right side |
| S04.21XS | Injury of trochlear nerve, right side, sequela |
| S04.52XA | Injury of facial nerve, initial encounter (listed as range S04.52XA- S04.52XS in table) |
| S04.52XS | Injury of facial nerve, sequela (part of listed range) |
| S04.60XD | Injury of acoustic nerve, unspecified side, subsequent encounter |
| S04.60XS | Injury of acoustic nerve, unspecified side, sequela |
| S04.61XA | Injury of acoustic (vestibulocochlear) nerve, right side (listed in ranges S04.61XA- S04.61XS) |
| S04.61XS | Injury of acoustic nerve, right side, sequela (part of range) |
| S04.62XA | Injury of acoustic nerve, left side (listed in ranges S04.62XA- S04.62XS) |
| S04.62XS | Injury of acoustic nerve, left side, sequela |
| S04.70XD | Injury of accessory nerve, unspecified side, subsequent encounter |
| S04.70XS | Injury of accessory nerve, unspecified side, sequela |
| S04.62XA- | Injury of trochlear nerve, right side / (trochlear nerve injury prefixes repeated) |
| S04.62XS | Injury of trochlear nerve, (sequala/unspecified forms appear in table) |
| S04.70XD | Injury of acoustic nerve, left side (and used for other entries) |
| S04.70XS | Injury of accessory nerve, unspecified side, subsequent encounter / sequela variants |
| S04.71XA- | Injury of accessory nerve, unspecified side, sequela / right-side variants |
| S04.71XS | Injury of accessory nerve, unspecified side, sequela variant |
| S04.72XA- | Injury of accessory nerve, right side / left side variants appear |
| S04.72XS | Injury of accessory nerve, left side (and sequela variants) |
| S04.811A- | Injury of olfactory [1st] nerve, right side (multiple encounter/sequela suffixes present) |
| S04.811S | Injury of olfactory [1st] nerve, right side (suffix variant) |
| S04.70XS | Injury of trochlear nerve, subsequent encounter (as listed in table context) |
| S04.71XA | Injury of accessory nerve, initial encounter (as listed in table context) |
| S04.71XS | Injury of accessory nerve, subsequent encounter |
| S04.72XA | Injury of accessory nerve, left/right variants listed (initial/subsequent encounter as repeated) |
| S04.72XS | Injury of accessory nerve, subsequent encounter |
| S04.811A | Injury of olfactory [1st] nerve, right side, initial encounter (table shows right/left/unspecified) |
| S04.811S | Injury of olfactory [1st] nerve, right side, sequela |
| S04.812A | Injury of olfactory [1st] nerve, left side, initial encounter |
| S04.812S | Injury of olfactory [1st] nerve, left side, sequela |
| S04.819A | Injury of olfactory [1st] nerve, unspecified side, initial encounter |
| S04.811A-S04.811S | Injury of accessory nerve, left side (range shown in table) |
| S04.812A-S04.812S | Injury of olfactory [1st] nerve, right side / left side / various side designations (ranges repeated) |
| S04.819A-S04.819S | Injury of olfactory [1st] nerve, left or unspecified side (range shown) |
| S04.891A-S04.891S | Injury of other cranial nerves, right side (range shown) |
| S04.892A-S04.892S | Injury of other cranial nerves, left side (range shown) |
| S04.899D | Injury of other cranial nerves, unspecified side, subsequent encounter (code appears in list) |
| S04.899S | Injury of other cranial nerves, unspecified side, sequela (code appears in list) |
| S04.72XA-S04.72XS | Injury of trochlear nerve, right side (range shown) |
| S04.71XS | Injury of trochlear nerve, right side (specific code appearance in chunks) |
| S04.9XXA-S04.9XXS | Injury of unspecified cranial nerve (range shown) |
Provider Requirements, Documentation, and Billing Guidance
Adhere to plan & policy criteria
Follow the applicable benefit plan document and this policy when submitting services; use the most appropriate codes as of the date of submission and submit services in accordance with the Coding Information section. Claims for services billed for conditions or diagnoses not covered under this policy will be denied as not covered.
Perform EMG/NCS with qualified staff and supervision
Needle EMG must be performed by a physician specially trained in electrodiagnostic medicine with real‑time interpretation; NCSs must be performed by a physician or a trained individual under the direct supervision of a physician, with the physician immediately available for assistance and responsible for selecting appropriate studies.
Document justification for repeat EDX testing
When repeat EDX testing is done beyond typical frequency limits, document the reason for the repeat study and compare results with prior tests in the report or patient chart.
- Include justification why additional testing is necessary (e.g., new/worsening symptoms, second EDX physician opinion, evaluation for a second diagnosis).
- Document comparisons to prior EDX results in the body of the report.
Use physician-trained interpreters; avoid automated-only devices
Electrodiagnostic studies (NCS and needle EMG) should be performed and interpreted by physicians with medical education in neuromuscular disorders and special training in electrodiagnostic testing; automated noninvasive devices are not supported as replacements.
- Individuals without neuromuscular medical education and special EDX training are not qualified to interpret waveforms.
- Automated portable NCV devices lack sufficient evidence and are not supported as substitutes for conventional EDX.
Bill combined NCV + EMG only when performed/interpreted together
If billing CPT codes for combined NCV and needle EMG, ensure the nerve conduction study was conducted and interpreted at the same time as the needle EMG and that both meet medical necessity criteria.
- CPT examples include 95885–95887 and 95907–95913 (see Coding Information).
- Performance and interpretation should be integrated into a single diagnostic impression on the same date of service.
No prior authorization stated in this section
This excerpt (Table 1: NCV code listings) does not specify any prior authorization requirements; the section provides diagnosis code mappings only.
Prior authorization not specified (diagnosis table)
No prior authorization requirements are specified in these chunks; content is limited to ICD-10 diagnosis mappings for the NCV table.
Prior authorization not specified in excerpt
No prior authorization requirements are stated in these chunks; only diagnosis code mappings are provided.
No prior authorization instructions provided here
This excerpt supplies diagnosis code mappings to be used with NCV claims but does not state explicit prior authorization requirements.
No prior authorization specified in this segment
This excerpt lists ICD-10 diagnosis codes associated with NCV and does not state prior authorization requirements for these services.
Prior authorization not specified in this excerpt
This excerpt consists solely of diagnosis codes assigned to Table 1 for NCV and does not describe any prior authorization requirements.
No prior authorization requirements listed
This excerpt lists diagnosis codes for NCV mapping and does not state any prior authorization requirements.
Prior authorization not specified for NCV diagnoses
This excerpt (Table 1) lists ICD-10 diagnosis codes related to NCV and does not state prior authorization requirements.
No prior authorization stated
No prior authorization requirements are specified in these chunks.
Prior authorization not stated in the code table
No prior authorization requirements are specified in these chunks; only diagnosis code listings are provided.
Require trial of conservative care (4–6 weeks) before invasive EDX in many cases
For many indications (e.g., radiculopathy, carpal tunnel), testing is medically necessary after failure of 4–6 weeks of conservative care unless clinical findings warrant earlier testing.
- Document prior conservative care (e.g., physical therapy, exercise, bracing) and lack of response when applicable.
Conservative care recommended before invasive testing
Conservative care such as 4–6 weeks of noninvasive treatment is generally appropriate prior to invasive electrodiagnostic procedures for many neck/back conditions unless objective clinical findings warrant earlier testing.
Perform NCS and needle EMG together except for documented exceptions
Except in limited clinical situations (e.g., limited follow‑up of previously evaluated structures, current anticoagulant use, lymphedema), NCS should be performed together with needle EMG and interpreted by the same physician.
- If NCS and EMG are dissociated, document the clinical exception and rationale.
Code accurately and perform concurrent interpretation
Providers must submit services with the most appropriate codes as of the effective date and include clinical information demonstrating pre‑test evaluation; interpretation should be completed at the time of testing and raw data and interpretation are expected to be performed concurrently.
Include focused history and neurologic exam in documentation
Clinical documentation must include the reason for the study, focused neurologic/physical exam (reflexes, sensory integrity, motor function), and rationale that results will influence treatment rather than a generic 'rule‑out' entry.
- Document specific neurologic exam findings (diminished reflexes, dermatome‑specific sensory loss, nerve‑root‑specific weakness) when present.
- Provide referral-source clinical history when applicable.
Submit complete EDX documentation (waveforms, numerical data, signatures)
Required documentation for EDX testing includes the clinical reason for the study, clinical history and exam findings, numerical NCS values (latency, amplitude, conduction), type of needle used, hard copy of waveforms, complete written report with interpretation, and names/signatures/professional designations of all individuals performing, interpreting, or supervising the test.
- Document limb temperatures and reference values (hand 32–36°C; foot 30–36°C).
- Include techniques, distances, lab reference values, and numerical data for all tests performed.
Avoid inadequate narrative-only documentation
Avoid narrative‑only reports that state only 'normal' or 'abnormal'; include numerical data (latency, amplitude), motor conduction data when describing F‑waves, and clear clinical history to support testing or repeat testing.
- Do not rely on pattern‑setting unilateral H‑reflex measurements alone.
- Provide justification for repeat testing in the chart or report.
Follow AANEM documentation standards for EMG/NCV
AANEM‑recommended documentation elements must be included: patient demographics, reason for referral, tests performed (techniques, distances, lab reference values), continuous limb temperature monitoring with hand 32–36°C and foot 30–36°C, all relevant numerical NCV/EMG data, and diagnostic interpretation including limitations.
Ensure code currency and avoid deleted/non‑effective codes
Maintain documentation consistent with coding updates and ensure deleted or non‑effective codes at the time of service are not billed.
Use Table 1 ICD‑10 codes for NCV claims
Reference Table 1: NCV ICD‑10 mappings when selecting diagnosis codes for nerve conduction study claims; use the appropriate ICD‑10 code from the table when submitting NCV claims.
- Absence of appropriate ICD‑10 coding that matches Table 1 may lead to coding/billing issues or denials.
Document an appropriate NCV diagnosis code from Table 1
Providers must document and bill NCV testing using an appropriate ICD‑10 diagnosis code from Table 1: NCV; this section enumerates valid diagnosis codes to be used for claims and documentation.
- Ensure diagnosis code selected matches the clinical presentation described in the medical record.
Claims without covered codes risk denial
Claims submitted for services not accompanied by covered code(s) under this policy will be denied as not covered.
Ensure direct physician supervision for NCS
NCS performed without the direct supervision of a trained electrodiagnostic physician is considered not medically necessary and may be denied.
- Direct supervision requires the physician to be in close physical proximity and immediately available during testing.
Document clinical findings that justify testing or risk denial
Failure to document a clinical history and focused neurologic examination showing findings suggestive of nerve insult or to show that testing would influence treatment planning may lead to denial.
- Document reflex changes, dermatome‑specific sensory deficits, or nerve‑root‑specific muscle weakness when present.
Do not submit claims for automated/template device-only testing
Claims for nerve conduction testing performed with discriminatory or automated devices that use fixed anatomic templates and computer‑generated reports routinely on all patients are not accepted.
- Automated device testing lacking real‑time clinician interpretation is not supported.
Provide real‑time numeric NCV/EMG parameters or risk denial
Diagnostic studies that do not provide required real‑time parameters (amplitude, latency, configuration, conduction velocity, limb temperature) or that provide delayed interpretation are not accepted and may be denied.
- Raw measurement data transmitted remotely without real‑time parameter reporting does not qualify for payment.
Remote/raw data only will not qualify for payment
Raw measurement data transmitted trans‑telephonically or over the Internet without required real‑time parameter reporting does not qualify for payment of electrodiagnostic service codes.
Inadequate documentation may cause denial
Inadequate documentation—missing clinical problem description, techniques, distances, lab reference values, temperature monitoring, numerical results, diagnostic interpretation and limitations—may lead to denial.
- Examples to avoid include narrative-only reports without numerical data and absence of referral-source clinical history.
Combined-code billing requires concurrent performance & interpretation
Failure to perform and interpret an NCV study at the same time as needle EMG when billing combined procedure codes could result in denial or downcoding if medical necessity criteria are not met.
Table 1 lists diagnosis codes only — no auth/denial rules here
This content is a diagnosis code mapping table for NCV and contains no explicit prior authorization or denial triggers; use the codes for claims while following other policy sections for medical necessity rules.
Use mapped ICD‑10 codes to avoid diagnosis‑coding mismatch
Absence of an appropriate ICD‑10 diagnosis code matching the Table 1 NCV mapping may lead to coding/billing issues or claim denials; select the mapped code that corresponds to the clinical condition.
NCV code table does not define authorization triggers
This segment only lists diagnosis codes associated with NCV testing and does not specify explicit authorization or denial triggers; ensure clinical documentation and coding align with other policy medical necessity sections.
Background and Rationale
Electrodiagnostic studies (nerve conduction studies/NCV and electromyography/EMG) evaluate peripheral nerve, muscle, and neuromuscular junction disorders and are used to localize pathology and inform diagnosis and management. These studies often must be individualized and interpreted in real time by clinicians trained in electrodiagnostic medicine because NCSs alone may be inadequate to establish diagnoses such as radiculopathy. Needle EMG provides additional information about muscle and motor unit integrity and, when combined with NCS, helps differentiate neuropathic, myopathic, and neuromuscular junction conditions.
Definitions and Test Modalities
Policy Revision History
Policy became effective on 2025-10-15.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.